Video

InQuest Science Cell & Gene Tech Expo August 2025: GMP And Regulatory Compliance

Source: InQuest Science

Cell and gene therapies should strive to meet the requirements of USP-790 to assure they are essentially free from particulate matter. They are generally produced aseptically where sterility is the most critical parameter. A well defined defect library and qualified inspectors are the first lines of defense to defect control. An expert database system for inspection defect management and control, such as The Identifier Software, streamlines this process.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

InQuest Science